ILMN

Illumina

$127.40

+5.53 (+4.54%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 27.02.2026
$136.05
(+6.79%)
Strong Buy: 1
Buy: 7
Hold: 8
Sell: 1
Strong Sell: 2
Description:
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
DIAGNOSTICS & RESEARCH
Address:
5200 ILLUMINA WAY, SAN DIEGO, CA, UNITED STATES, 92122
Fiscal year end:
December
Market capitalization:
$18.6 Billion
EBITDA:
$1.14 Billion
PERatio:
22.57
EPS:
5.4
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.449

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-6%
How much will you get:
$942
Prices dates:
29-01-2016: $153.65 and 30-01-2026: $144.81